Compass Therapeutics, Inc.
CMPX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001738021
In the last 90 days, Compass Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; 215 institutions reported holding it in 13F filings for Q2 2026, worth $363.4M in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Compass Therapeutics, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 34
- −3 vs. Q4 2021
- Shares held
- 62.4M
- −1.19M (−1.9%) vs. Q4 2021
- Total value
- $85.4M
- −$116.3M (−57.7%) vs. Q4 2021
- New holders
- 7
- 6 more added
- Sold out
- 10
- 5 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CMPX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 215 | $363.4M |
| Q1 2026 | 201 | $921.3M |
| Q4 2025 | 173 | $881.5M |
| Q3 2025 | 125 | $528.7M |
| Q2 2025 | 103 | $281.5M |
| Q1 2025 | 108 | $206.1M |
| Q4 2024 | 92 | $147.0M |
| Q3 2024 | 79 | $169.6M |
| Q2 2024 | 82 | $93.4M |
| Q1 2024 | 78 | $187.2M |
| Q4 2023 | 77 | $134.3M |
| Q3 2023 | 76 | $176.7M |
| Q2 2023 | 73 | $287.7M |
| Q1 2023 | 73 | $266.5M |
| Q4 2022 | 55 | $401.4M |
| Q3 2022 | 38 | $145.6M |
| Q2 2022 | 34 | $163.9M |
| Q1 2022 | 34 | $85.4M |
| Q4 2021 | 37 | $201.6M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Compass Therapeutics, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bank of America Corp | 6 | $0 | 0.00% | +6 | New |
| Royal Bank of Canada | 783 | $1.00K | 0.00% | +783 | New |
| Charter Oak Capital Management, LLC | 1,483 | $2.00K | 0.00% | +1,483 | New |
| UBS Group AG | 7,228 | $10.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 13,300 | $18.0K | 0.00% | +13,300 | New |
| B. Riley Wealth Management, Inc. | 14,918 | $20.0K | 0.00% | +14,918 | New |
| Mascoma Wealth Management LLC | 15,682 | $21.0K | 0.01% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 24,857 | $34.0K | 0.00% | +24,857 | New |
| Morgan Stanley | 26,977 | $37.0K | 0.00% | +9,504+54.4% | Added |
| Millennium Management LLC | 38,545 | $53.0K | 0.00% | +27,388+245.5% | Added |
| Qube Research & Technologies Ltd | 52,842 | $72.0K | 0.00% | +23,789+81.9% | Added |
| Ikarian Capital, LLC | 74,171 | $100.0K | 0.03% | +4,171+6.0% | Added |
| Salem Investment Counselors Inc | 100,000 | $137.0K | 0.01% | 00.0% | Unchanged |
| LMR Partners LLP | 100,000 | $137.0K | 0.00% | 00.0% | Unchanged |
| Alphabet Inc. | 192,794 | $264.0K | 0.01% | 00.0% | Unchanged |
| DAFNA Capital Management LLC | 196,091 | $269.0K | 0.07% | 00.0% | Unchanged |
| CM Management, LLC | 300,000 | $411.0K | 0.35% | +300,000 | New |
| Ra Capital Management, L.P. | 532,958 | $730.0K | 0.02% | −1,316,560−71.2% | Reduced |
| Farallon Capital Management, L.L.C. | 582,750 | $798.0K | 0.00% | −417,250−41.7% | Reduced |
| Fred Alger Management, LLC | 608,536 | $834.0K | 0.00% | −210,209−25.7% | Reduced |
| Foresite Capital Opportunity Management V, LLC | 1,100,000 | $1.51M | 2.11% | 00.0% | Unchanged |
| Monashee Investment Management LLC | 1,270,211 | $1.74M | 0.50% | −729,789−36.5% | Reduced |
| Blackstone Group Inc. | 1,505,738 | $2.06M | 0.01% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,572,882 | $2.15M | 0.00% | 00.0% | Unchanged |
| Vivo Capital, LLC | 2,000,000 | $2.74M | 0.19% | 00.0% | Unchanged |
| Avidity Partners Management LP | 2,000,000 | $2.74M | 0.06% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 2,277,000 | $3.12M | 0.01% | +877,000+62.6% | Added |
| CHI Advisors LLC | 2,829,712 | $3.88M | 1.65% | −193,980−6.4% | Reduced |
| Janus Henderson Group PLC | 3,193,294 | $4.33M | 0.00% | +1,720,683+116.8% | Added |
| Consonance Capital Management LP | 3,500,000 | $4.74M | 8.05% | 00.0% | Unchanged |
| Foresite Capital Management V, LLC | 4,400,000 | $6.03M | 2.46% | 00.0% | Unchanged |
| Rock Springs Capital Management LP | 5,328,088 | $7.30M | 0.18% | 00.0% | Unchanged |
| FMR LLC | 6,872,414 | $9.42M | 0.00% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 21,642,975 | $29.7M | 0.48% | 00.0% | Unchanged |
| Sphera Funds Management Ltd. | 0 | $0 | 0.00% | −700,000−100.0% | Sold out |
| Driehaus Capital Management LLC | 0 | $0 | 0.00% | −250,000−100.0% | Sold out |
| Octagon Capital Advisors LP | 0 | $0 | 0.00% | −240,000−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −37,834−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −33,573−100.0% | Sold out |
| New Capital Management LP | 0 | $0 | 0.00% | −24,243−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −23,749−100.0% | Sold out |
| Mirabella Financial Services LLP | 0 | $0 | 0.00% | −18,880−100.0% | Sold out |
| Difesa Capital Management, LP | 0 | $0 | 0.00% | −10,337−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −3,205−100.0% | Sold out |